Filing Details
- Accession Number:
- 0000721371-13-000128
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-12 08:57:34
- Reporting Period:
- 2013-08-08
- Filing Date:
- 2013-08-12
- Accepted Time:
- 2013-08-12 08:57:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
721371 | Cardinal Health Inc | CAH | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 310958666 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1227732 | Calvin Darden | 7000 Cardinal Place Dublin OH 43017 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares | Acquisiton | 2013-08-08 | 3,254 | $46.49 | 21,385 | No | 4 | M | Direct | |
Common Shares | Disposition | 2013-08-08 | 3,254 | $51.48 | 18,131 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Stock Option (right to buy) | Disposition | 2013-08-08 | 3,254 | $0.00 | 3,254 | $46.49 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2007-11-08 | 2013-11-08 | No | 4 | M | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.482 to $51.485, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.